Randomized trial of Legflow® paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial

BACKGROUND: Restenosis after percutaneous transluminal angioplasty (PTA) of the superficial femoral artery (SFA) may occur in 45% of patients at 2 years follow-up. Paclitaxel-coated balloons have been found to reduce neointimal hyperplasia, and thus reduce restenosis. Recently, the Legflow® paclitax...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi, Amine, de Boer, Sanne W, van den Heuvel, Daniël AF, Fioole, Bram, Vroegindeweij, Dammis, Heyligers, Jan MM, Lohle, Paul NM, Elgersma, Otto, Nolthenius, Rudolf PT, Vos, Jan Albert, de Vries, Jean-Paul PM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651710/
https://www.ncbi.nlm.nih.gov/pubmed/23537403
http://dx.doi.org/10.1186/1745-6215-14-87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651710/
https://www.ncbi.nlm.nih.gov/pubmed/23537403
http://dx.doi.org/10.1186/1745-6215-14-87

Ejemplares similares